163 related articles for article (PubMed ID: 36058028)
1. Ru(II)-modified TiO
Zhou JY; Wang WJ; Zhang CY; Ling YY; Hong XJ; Su Q; Li WG; Mao ZW; Cheng B; Tan CP; Wu T
Biomaterials; 2022 Oct; 289():121757. PubMed ID: 36058028
[TBL] [Abstract][Full Text] [Related]
2. Cellular Hypoxia Mitigation by Dandelion-like Nanoparticles for Synergistic Photodynamic Therapy of Oral Squamous Cell Carcinoma.
Tao Y; Liu Y; Dong Z; Chen X; Wang Y; Li T; Li J; Zang S; He X; Chen D; Zhao Z; Li M
ACS Appl Mater Interfaces; 2022 Oct; 14(39):44039-44053. PubMed ID: 36153957
[TBL] [Abstract][Full Text] [Related]
3. Overcoming chemotherapy resistance using pH-sensitive hollow MnO
Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP
J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370
[TBL] [Abstract][Full Text] [Related]
4. PX-12 synergistically enhances the therapeutic efficacy of vorinostat under hypoxic tumor microenvironment in oral squamous cell carcinoma in vitro.
Akhlaq R; Khan T; Ahmed T; Musharraf SG; Ali A
Drug Dev Res; 2023 May; 84(3):556-560. PubMed ID: 36808757
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol Metabolism Modulation Nanoplatform Improves Photo-Immunotherapeutic Effect in Oral Squamous Cell Carcinoma.
Zhang X; Cao Z; Song C; Wei Z; Zhou M; Chen S; Ran J; Zhang H; Zou H; Han S; Cai Y; Han W
Adv Healthc Mater; 2023 Sep; 12(22):e2300018. PubMed ID: 37209373
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer.
Chen WH; Lecaros RL; Tseng YC; Huang L; Hsu YC
Cancer Lett; 2015 Apr; 359(1):65-74. PubMed ID: 25596376
[TBL] [Abstract][Full Text] [Related]
7. Differentiated embryo chondrocyte 1, induced by hypoxia-inducible factor 1α, promotes cell migration in oral squamous cell carcinoma cell lines.
Yang L; Zeng L; Wang Z; Hu X; Xiong H; Zhang T; Chen W; Xia K; Su T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Feb; 133(2):199-206. PubMed ID: 34758939
[TBL] [Abstract][Full Text] [Related]
8. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
10. A Bacterial Nanomedicine Combines Photodynamic-Immunotherapy and Chemotherapy for Enhanced Treatment of Oral Squamous Cell Carcinoma.
Shi E; Shan T; Wang H; Mao L; Liang Y; Cao M; Wu Q; Li C; Wang Y; Wang Y
Small; 2023 Dec; 19(52):e2304014. PubMed ID: 37653616
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression.
Kim S; Park S; Oh JH; Lee SS; Lee Y; Choi J
BMC Oral Health; 2022 Sep; 22(1):378. PubMed ID: 36064348
[TBL] [Abstract][Full Text] [Related]
12. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
13. The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells.
Sasabe E; Zhou X; Li D; Oku N; Yamamoto T; Osaki T
Int J Cancer; 2007 Jan; 120(2):268-77. PubMed ID: 17066447
[TBL] [Abstract][Full Text] [Related]
14. RNA interference-mediated downregulation of hypoxia-inducible factor-1α inhibits angiogenesis and survival of oral squamous cell carcinoma in vitro and in vivo.
Zhou H; Fei W; Bai Y; Zhu S; Luo E; Chen K; Hu J
Eur J Cancer Prev; 2012 May; 21(3):289-99. PubMed ID: 22113109
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1alpha expression in oral squamous cell carcinoma cells.
Sasabe E; Yang Z; Ohno S; Yamamoto T
Free Radic Biol Med; 2010 May; 48(10):1321-9. PubMed ID: 20188165
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma.
Iwata E; Hasegawa T; Takeda D; Ueha T; Kawamoto T; Akisue T; Sakai Y; Komori T
Int J Oncol; 2016 Apr; 48(4):1493-8. PubMed ID: 26846904
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of chitosan nanoparticles of 5-aminolevulinic acid and shGBAS for improving photodynamic therapy efficacy in oral squamous cell carcinomas.
Wang X; Li S; Liu H
Photodiagnosis Photodyn Ther; 2021 Jun; 34():102218. PubMed ID: 33592329
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
19. Exploring the therapeutic potential of curcumin in oral squamous cell carcinoma (HSC-3 cells): Molecular insights into hypoxia-mediated angiogenesis.
Jayaraman S; Veeraraghavan VP; Natarajan SR; Jasmine S
Pathol Res Pract; 2024 Feb; 254():155130. PubMed ID: 38277750
[TBL] [Abstract][Full Text] [Related]
20. Siah-1 is associated with expression of hypoxia-inducible factor-1α in oral squamous cell carcinoma.
Aga M; Kondo S; Wakisaka N; Moriyama-Kita M; Endo K; Nakanishi Y; Murono S; Sugimoto H; Ueno T; Yoshizaki T
Auris Nasus Larynx; 2017 Apr; 44(2):213-219. PubMed ID: 27616748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
